![Microorganisms | Free Full-Text | Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia Microorganisms | Free Full-Text | Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia](https://www.mdpi.com/microorganisms/microorganisms-09-02282/article_deploy/html/images/microorganisms-09-02282-g001.png)
Microorganisms | Free Full-Text | Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia
![Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report | European Respiratory Society Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report | European Respiratory Society](https://erj.ersjournals.com/content/erj/54/6/1901522/F2.large.jpg)
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report | European Respiratory Society
![Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study - eClinicalMedicine Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/1ff53b84-d8d3-4067-a4a3-471b12895664/gr1.jpg)
Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study - eClinicalMedicine
![The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda - The Lancet Respiratory Medicine The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/03a39f47-20f9-4e40-b684-ac8e8acd72b1/gr1_lrg.jpg)
The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda - The Lancet Respiratory Medicine
![Common adverse effects of drugs used for the treatment of extensive-and... | Download Scientific Diagram Common adverse effects of drugs used for the treatment of extensive-and... | Download Scientific Diagram](https://www.researchgate.net/publication/304396888/figure/tbl1/AS:614288410558466@1523469178012/Common-adverse-effects-of-drugs-used-for-the-treatment-of-extensive-and.png)
Common adverse effects of drugs used for the treatment of extensive-and... | Download Scientific Diagram
![Anti-tuberculosis treatment strategies and drug development: challenges and priorities | Nature Reviews Microbiology Anti-tuberculosis treatment strategies and drug development: challenges and priorities | Nature Reviews Microbiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41579-022-00731-y/MediaObjects/41579_2022_731_Fig1_HTML.png)
Anti-tuberculosis treatment strategies and drug development: challenges and priorities | Nature Reviews Microbiology
![Frontiers | Long-Term Effects of Multi-Drug-Resistant Tuberculosis Treatment on Gut Microbiota and Its Health Consequences Frontiers | Long-Term Effects of Multi-Drug-Resistant Tuberculosis Treatment on Gut Microbiota and Its Health Consequences](https://www.frontiersin.org/files/Articles/500124/fmicb-11-00053-HTML/image_m/fmicb-11-00053-g001.jpg)